Generic Drug Immunosuppression in Thoracic Transplantation: An ISHLT Educational Advisory
Received 1 May 2009; received in revised form 1 May 2009; accepted 1 May 2009. published online 04 June 2009.
No abstract is available. To read the body of this article, please view the Full Text online.
aDivision of Cardiology, University of Maryland School of Medicine, Baltimore, Maryland
bDivision of Cardiology, Peter Munk Cardiac Centre, Toronto General Hospital, Toronto, Ontario, Canada
cDepartment of Cardiothoracic Surgery, Medical University of Vienna, Währinger Gürtel, Vienna, Austria
dDivision of Allergy and Pulmonary Medicine, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri
eNewcastle University and Cardiothoracic Centre, Freeman Hospital, Newcastle upon Tyne, UK
fQueensland Centre for Thoracic Transplantation, The Prince Charles Hospital, Chermside, Brisbane, Queensland, Australia
Reprint requests: Mandeep R. Mehra, MBBS, Department of Cardiology, University of Maryland Medical Center, 22 South Greene Street, S3B06, Baltimore, MD 21030. Telephone: 410-328-7716. Fax: 410-328-4382
Presented in part at the 29th annual scientific meeting of the ISHLT, April 2009, Paris, France. This study was commissioned by the Board of Directors of the ISHLT and approved at all stages by the Education Committee of the ISHLT.
